How the interaction occurs:
Antacids that contain aluminum and/or magnesium may bind to some cephalosporins in your stomach and intestines and prevent your body from absorbing them.
What might happen:
The amount of antibiotic in your blood may decrease and it may not work as well against your infection.
What you should do about this interaction:
If you have to take an antacid containing aluminum and/or magnesium, make sure that you take it at least 2 hours before or after your antibiotic. Let your healthcare professional (e.g. doctor or pharmacist) know if your infection does not seem to be getting better.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Omnicef (cefdinir) US prescribing information. Abbott Laboratories December, 2008.
2.Saathoff N, Lode H, Neider K, Depperman KM, Borner K, Koeppe P. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Antimicrob Agents Chemother 1992 Apr; 36(4):796-800.
3.Vantin (cefpodoxime proxetil) US prescribing information. Pharmacia & Upjohn Company April, 2007.
4.Blouin RA, Kneer J, Ambros RJ, Stoeckel K. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob Agents Chemother 1990 Sep;34(9):1744-8.
5.Healy DP, Sahai JV, Sterling LP, Racht EM. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime. Antimicrob Agents Chemother 1989 Nov;33(11):1994-7.
6.Shyu WC, Wilber RB, Pittman KA, Barbhaiya RH. Effect of antacid on the bioavailability of cefprozil. Antimicrob Agents Chemother 1992 May; 36(5):962-5.
7.Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P. Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1989 Nov;33(11):1901-7.